BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1317 related articles for article (PubMed ID: 8827359)

  • 1. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.
    Daling JR; Madeleine MM; McKnight B; Carter JJ; Wipf GC; Ashley R; Schwartz SM; Beckmann AM; Hagensee ME; Mandelson MT; Galloway DA
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):541-8. PubMed ID: 8827359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK
    APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based study of squamous cell vaginal cancer: HPV and cofactors.
    Daling JR; Madeleine MM; Schwartz SM; Shera KA; Carter JJ; McKnight B; Porter PL; Galloway DA; McDougall JK; Tamimi H
    Gynecol Oncol; 2002 Feb; 84(2):263-70. PubMed ID: 11812085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
    Rosenquist K
    Swed Dent J Suppl; 2005; (179):1-66. PubMed ID: 16335030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study.
    Hildesheim A; Han CL; Brinton LA; Kurman RJ; Schiller JT
    Obstet Gynecol; 1997 Nov; 90(5):748-54. PubMed ID: 9351758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix.
    Madeleine MM; Daling JR; Schwartz SM; Shera K; McKnight B; Carter JJ; Wipf GC; Critchlow CW; McDougall JK; Porter P; Galloway DA
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):171-7. PubMed ID: 11303584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking.
    Castellsagué X; Muñoz N
    J Natl Cancer Inst Monogr; 2003; (31):20-8. PubMed ID: 12807941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus.
    Shields TS; Brinton LA; Burk RD; Wang SS; Weinstein SJ; Ziegler RG; Studentsov YY; McAdams M; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1574-82. PubMed ID: 15466972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica.
    Hildesheim A; Herrero R; Castle PE; Wacholder S; Bratti MC; Sherman ME; Lorincz AT; Burk RD; Morales J; Rodriguez AC; Helgesen K; Alfaro M; Hutchinson M; Balmaceda I; Greenberg M; Schiffman M
    Br J Cancer; 2001 May; 84(9):1219-26. PubMed ID: 11336474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
    Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
    J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy between cigarette smoking and human papillomavirus type 16 in cervical cancer in situ development.
    Gunnell AS; Tran TN; Torrång A; Dickman PW; Sparén P; Palmgren J; Ylitalo N
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2141-7. PubMed ID: 17057029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomaviruses and other influences on survival from cervical cancer in Panama.
    DeBritton RC; Hildesheim A; De Lao SL; Brinton LA; Sathya P; Reeves WC
    Obstet Gynecol; 1993 Jan; 81(1):19-24. PubMed ID: 8380103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cancer of the cervix, papillomavirus, contraception and tobacco].
    Thiry L; Vokaer R; Detremmerie O; De Schepper N; Herzog A; Bollen A
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(5):477-86. PubMed ID: 8228010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
    Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
    N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
    Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
    Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas.
    Lacey JV; Brinton LA; Abbas FM; Barnes WA; Gravitt PE; Greenberg MD; Greene SM; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Silverberg SG; Hildesheim A
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1079-85. PubMed ID: 10613340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997.
    Miller CS; Johnstone BM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jun; 91(6):622-35. PubMed ID: 11402272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus cervical infection and associated risk factors in a region of Argentina with a high incidence of cervical carcinoma.
    Tonon SA; Picconi MA; Zinovich JB; Liotta DJ; Bos PD; Galuppo JA; Alonio LV; Ferreras JA; Teyssié AR
    Infect Dis Obstet Gynecol; 1999; 7(5):237-43. PubMed ID: 10524669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys.
    Vaccarella S; Herrero R; Dai M; Snijders PJ; Meijer CJ; Thomas JO; Hoang Anh PT; Ferreccio C; Matos E; Posso H; de Sanjosé S; Shin HR; Sukvirach S; Lazcano-Ponce E; Ronco G; Rajkumar R; Qiao YL; Muñoz N; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2148-53. PubMed ID: 17119039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
    Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.